MENA Metabolic Conference
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Product News

Product News

C142

Test for cytomegalovirus

, 26 August 2020/in Product News /by 3wmedia

As with other members of the herpes virus family, cytomegalovirus (CMV) is typically latent after primary infection. It can reactivate when the immune system is significantly weakened, such as following organ transplantation, and cause fever, organ rejection and even death. Focus diagnostics’ Simplexa CMV molecular test kit on the 3M Integrated Cycler is now available in Europe. The test is designed to enable hospital labs to perform advanced molecular testing for CMV in patients with compromised immunity, particularly those undergoing organ transplantation. The test employs RT PCR to quantitatively detect CMV in whole blood specimens and plasma.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C142.jpg 100 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:542021-01-08 11:29:47Test for cytomegalovirus
C009 orgentec1

Calprotectin assay

, 26 August 2020/in Product News /by 3wmedia

Abdominal pain and diarrhoea are common symptoms of conditions ranging from chronic inflammatory bowel disease to infections of the digestive tract, celiac disease or irritable bowel syndrome. Complete blood count and other inflammatory parameters in the blood are also not specific to inflammation localized in the intestines, so diagnoses of inflammatory bowel disease are often made with considerable delay. On the other hand, people with functional diseases, such as irritable bowel syndrome are often referred to painful and actually needless diagnostic procedures. Calprotectin in stool is an ideal marker for differentiation between intestinal inflammation and irritable bowel syndrome. Elevated levels of calprotectin in stool samples are found in cases of inflammatory bowel disease, infectious gastroenteritis, or colorectal carcinoma. For functional disorders like irritable bowel syndrome, and in celiac disease, calprotectin levels are within the normal range. The detection of fecal calprotectin is a simple, non-invasive test that can reasonably be carried out before any imaging or endoscopy, and thus helps to avoid unnecessary, painful and costly colonoscopies in patients with functional diarrhoea. The non-invasive calprotectin tests can easily be performed in children and pregnant women, with no adverse effects. Calprotectin concentrations correlate with disease activity in ulcerative colitis and Crohn’s disease. They decline with response to therapy, and increasing calprotectin levels may indicate relapses even before clinical symptoms become evident. Calprotectin in stool samples is an accurate early indicator for intestinal inflammation and is now available for Orgentec’s Alegria instrument with fully automated walk-away design. The Alegria system allows for rapid automated analysis of single samples and up to 30 tests in only 90 minutes. There are no limits for sample selection. Laboratory parameters from autoimmunity (e.g. if celiac disease is suspected) or infectious disease serology can be analysed simultaneously in one single automated Alegria test run.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C009_orgentec1.jpg 95 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:542021-01-08 11:29:50Calprotectin assay
C029 Gonotec

Freezing point osmometer

, 26 August 2020/in Product News /by 3wmedia

Designed for routine measurements in the medical field and for measurements in research and industry, the Osmomat 3000 determines the total osmolality of aqueous solutions. It requires very small sample volumes and can thus be applied for extreme measuring tasks. Its rapidity allows serial measurements in a very short time. It can be easily controlled via a touch screen display and the step by step user guidance through all measurements functions. The desired language can be chosen. The Osmomat 3000 simplifies the QM assistance for the laboratory supervisor. The measurement results are sent to the optional builtin printer in document-ready format or the data can be transferred to a PC by connection via USB or RS232. The robust design makes the instrument easy to handle and maintain.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C029_Gonotec.jpg 150 122 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:542021-01-08 11:29:53Freezing point osmometer
C253 Roche

Reliable, automated nucleic acid extraction

, 26 August 2020/in Product News /by 3wmedia

Providing high lot-to-lot consistency and quality the MagNA Pure 96 System for automated sample preparation is able to purify a broad spectrum of human samples and offers LIMS (laboratory information management system) connectivity for safer and more convenient data transfer. It provides ready-to-use reagents and uses a minimal number of consumables for purification of nucleic acids from up to 96 clinical samples in less than 60 minutes. The instrument performance characteristics of MagNA Pure have been established in external trials with model parameters. This platform is ideal for clinical trials, medical research and molecular diagnostic testing that requires consistent high-quality sample analysis.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C253_Roche.jpg 112 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:232021-01-08 11:29:19Reliable, automated nucleic acid extraction
BindingSite

Human clinical specimens

, 26 August 2020/in Product News /by 3wmedia

In addition to its already broad offering of clinical and research based products for the in vitro diagnostics and life sciences industries, Binding Site now offers human clinical specimens to both IVD manufacturers and suppliers. The availability and sourcing of high quality clinical specimens is vital in ensuring the scientific relevance and validity of clinical instrumentation and reagent applications. In addition, these specimens are also necessary for a host of other critical studies, including new product development work, validation studies and ongoing technical support projects. Compliant with all regulatory and quality standards guidelines, the clinical specimens can be provided in a variety of different matrices, which can be further characterised by specific analyte and concentration/titre, along with additional information on age, gender and disease state. Specimen volumes are available in a variety of configurations ranging from millilitres up to litre volumes, and are offered in a variety of formats (i.e. pooled sera/plasma, single donor, dialysed serum, etc.). All necessary documentation and paperwork is supplied with each shipment.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/BindingSite.jpg 68 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:232021-01-08 11:29:27Human clinical specimens
C154

Aspergillus detection test

, 26 August 2020/in Product News /by 3wmedia

An evaluation to detect invasive Aspergillosis (IA) in a mixed population of 158 patients with underlying haematological or critical illness using the new commercial PCR test, the MycAssay, has been completed. The single-centre prospective evaluation tested the reliability and performance of the assay compared with clinical diagnosis and conventional diagnostic tests, such as culture and one of the current commercial gold-standards which is based around the detection of galactomannan (GM) in serum. The data generated from bronchoalveolar lavage [BAL] samples showed that the assay is a sensitive and specific molecular test for the diagnosis of IA which, in these early studies, appears to perform better than other assays in the study and is far superior to culture. Invasive aspergillosis is usually a hidden, clinical silent disease. Early detection of IA is critical for improved patient outcomes. Current tests are insensitive or suffer from false-positive and false-negative results. These new data are very promising in the context of haematological or critical illness and hopefully can be introduced into routine fungal disease guidelines at the earliest opportunity.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C154.jpg 99 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:232021-01-08 11:29:37Aspergillus detection test
C196 Thermo

Single-use syringe filters

, 26 August 2020/in Product News /by 3wmedia

Designed specifically for sample preparation, the single-use Titan3 and Target2 ranges of syringe filters accommodate greater burst pressures and provide exceptional flow-through characteristics. Previously supplied as the SUN-Sri TITAN2 and National Scientific Target ranges, the new filter units offer increased reliability and performance, including an improved housing design that prevents leakage during filtration. The premium Titan3 range has colour-coded housings for easy membrane selection and an integral ring that withstands even greater burst pressures: the 30mm models are resistant to pressures of up to 120psi. Both filter ranges are fully HPLC-tested and incorporate low extractable membranes and housings. The filters are available in a wide range of filtration membrane types and porosities and are suitable for a range of chromatography filtration applications.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C196_Thermo.jpg 100 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:232021-01-08 11:29:22Single-use syringe filters
C192

Rapid molecular diagnostic tests for pathogens

, 26 August 2020/in Product News /by 3wmedia

Marking a significant advance in speed to results and ease-of-use, the new QuickFISH rapid pathogen tests helps clinical microbiologists and infectious diseases clinicians to optimise antibiotic therapy and care much earlier for patients with sepsis. This rapid, molecular diagnostic platform is based on proprietary PNA probe technology. It enables very fast (20 minutes) identification of bacteria directly from complex samples such as positive blood cultures, with clinical microbiologists obtaining results for causative pathogens, such as S. aureus, E. faecium, P. aeruginosa and Candida species, in time to report these together with Gram stain results. This, in turn, allows therapy selection to be based on more specific information at a critical antibiotic decision point for patients with sepsis. Only limited instrumentation and five minutes of hands-on time are needed for tests, simplifying and streamlining laboratory workflow. The built-in, universal controls ensure confidence in every test result.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C192.jpg 119 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:232021-01-08 11:29:32Rapid molecular diagnostic tests for pathogens
C172

Five infectious disease panels

, 26 August 2020/in Product News /by 3wmedia

Five new infectious disease panels, including a first-of-its-kind performance panel for parvovirus B19 have been launched. The HIV Genotype Performance Panel provides researchers with a diverse set of samples, both geographically and in terms of genotypes: eight of the nine panel members are HIV positive, representing eight different HIV-1 genotypes from seven countries. Made from cultured virus diluted in defibrinated plasma, this unique panel is designed to help researchers, manufacturers and labs develop, evaluate and troubleshoot a variety of HIV assays, including those for HIV RNA and the newest screening tests for combined HIV antigen and antibody. The Worldwide HBV DNA Performance Panel is a 20-member panel including samples from 10 countries with HBV genotypes ranging from A to H. It delivers a broad range of data, with information on genotype, drug resistance mutations and test results for, HBV DNA, HBsAg and HbeAg. The Anti-Hepatitis A Virus Mixed Titer Performance Panel offers customers a 21-member panel that includes members positive for IgG and IgM, contains specimens collected from 2000 to 2010, and represents a diverse range of HAV reactivities (from low to medium to high). Data are available for both new and established test methods, providing greater applicability across a broad range of laboratory and research settings. The Anti-CMV (Cytomegalovirus) Mixed Titer Performance Panel provides 21 naturally occurring panel members with data from twelve commercially available anti-CMV assays. It also features a detailed graphical representation of test member results, making it easier than ever to find and utilise relevant data. These five new infectious disease panels, as well as a diverse selection of other infectious disease panels, are available immediately worldwide.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C172.jpg 100 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:232021-01-08 11:29:40Five infectious disease panels
C248 Genalyte

One-step screening for common connective tissue disease autoantibodies

, 26 August 2020/in Product News /by 3wmedia

Created to simultaneously screen for several of the most common autoantibodies found in autoimmune connective tissue disorders, such as systemic lupus erythematosus (SLE), the Maverick ENA 4 and ENA 6 assay kits are the first available for the Maverick Detection System. Their simplified one-step workflow delivers accurate results in 15 minutes and can be run using very small volume samples from a variety of matrices, including serum and plasma. The ENA 4 assay tests for the presence of four of the most commonly measured extractable nuclear antigens (ENA), including SS-A, SS-B, Sm and RNP, while the ENA 6 assay includes two additional commonly measured antigens–Scl-70 and Jo-1, so covering six multiplexed tests per sample. The assay results are highly reproducible, show excellent correlation to ELISA and are up to ten times more sensitive. The assays are available to participants in the company’s Early Access programme, which enables scientists to gain pre-launch access to multiplexed autoantibody assays and the Maverick Detection System. This uses a proprietary chip based on silicon photonics to simultaneously analyse multiple proteins from a single small sample. The multiplexing technology simultaneously screens for the detection of autoantibodies using a one-step process that eliminates the washes, incubations, reagents and processing steps typically associated with other technologies. Semi-quantitative results are reported for each analyte, eliminating the need for reflex testing. The assays are simple to use and rapid – results are available in only 15 minutes, including just two minutes of hands-on time. A number of higher plexed assays for autoimmune diseases, including rheumatoid arthritis, celiac disease and others, are also in development.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C248_Genalyte.jpg 175 120 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:20:232021-01-08 11:29:15One-step screening for common connective tissue disease autoantibodies
Page 75 of 152«‹7374757677›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

March 2026

CLi Cover MRCH 2026
11 March 2026

Isomorphic Labs unveils IsoDDE, a unified AI drug design engine surpassing AlphaFold 3 in biomolecular prediction

11 March 2026

Androgen testing for PCOS diagnosis

9 March 2026

DiaSys Diagnostic Systems | ACE FS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription